骨髓性恶性瘤中介质体细胞:免疫治疗机会
Milica Vukotić1, Suncica Kapor2, Felipe Simon3,4,5
1Molecular Oncology Group, Institute for Medical Research, University of Belgrade, Belgrade, Serbia.
Heliyon
|February 5, 2024
概括
介质细胞 stromal 细胞 (MSCs) 通过抑制免疫系统,为骨髓性恶性瘤创造一个支持性的微环境. 向MSC可能为髓性恶性瘤免疫治疗提供新的途径.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 骨髓瘤恶性瘤是影响造血干细胞的克隆性疾病.
- 这些癌症会破坏正常的血细胞生产,导致严重的并发症.
- 骨髓中介质体细胞 (MSC) 在免疫抑制中起着至关重要的作用.
研究的目的:
- 在骨髓瘤恶性瘤的背景下,审查MSCs的多方面的作用.
- 探索MSCs如何促进免疫逃避和疾病进展.
- 突出针对MSCs的潜力,用于新型免疫疗法.
主要方法:
- 对MSCs和骨髓质恶性瘤现有研究的文献综述.
- 分析MSC功能,包括免疫抑制,细胞生长调节和耐药性.
- 综合发现,以了解MSCs的临床影响.
主要成果:
- MSCs具有显著的免疫抑制功能,为癌细胞创造了一个耐受性的微环境.
- 多重瘤细胞会影响骨髓性恶性瘤细胞生长,存活率和抗癌治疗的抵抗力.
- 这些细胞积极促进髓状细胞癌症的进展和严重程度.
结论:
- MSCs是骨髓利基内的关键调节者,支持骨髓恶性瘤的发展.
- 了解MSC介导的机制对于开发有效的治疗方法至关重要.
- 针对MSCs为未来的免疫治疗方法提供了一个有希望的策略,用于髓状瘤恶性瘤.
相关概念视频
Mesenchymal Stem Cells
4.7K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.7K
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Bone Marrow Sampling and Transplants
331
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
331


